DT Technology Group Partners With Virtuozzo to Accelerate Transformation Into a Leading Digital Platform Enabler
13.10.2021 14:00:00 EEST | Business Wire | Press release
Virtuozzo, a global leader in high-efficiency virtualization and hyperconverged software solutions, today announced its collaboration with DT Technology Group has accelerated DT’s transition from a leading telco to a leading digital platform enabler. Through the use of Virtuozzo Hybrid Infrastructure, DT has deployed a Public Cloud as well as new revenue streams via DevOps services—all while reducing its total cost of ownership by 30 percent.
Increasingly, companies seek to leverage digital solutions to transform their businesses. Simultaneously, SmartCity projects show no signs of slowing down. However, the continued growth of 5G connectivity and IoT applications brings with it new infrastructure design challenges—integration of AI computing, Cloud Native applications, GPU computing, application modernization, and DevOps resources. The supporting network infrastructure must be robust enough to scale with the demand while the software development ecosystem around it must be mature enough to enable enterprises as well as small- to medium-sized companies to leverage the technology trends for business gain.
Drawing on its ICT system integration and telecom roots, DT sought to address both needs by building an enterprise-grade and 5G-ready infrastructure as well as establishing a team of skilled digital software developers. In the late 2010’s, the company launched its Cloud platform and digital software solutions suite via partnerships with a hyperscaler and proprietary virtualization solutions provider, though quickly sought to replace them… and did with a single partner: Virtuozzo.
“We have a unique market opportunity. We understand the infrastructure requirements behind carrier grade platforms and are leveraging this expertise to build seamless, elastic enterprise-grade digital platforms,” said Tolga Dinçer, CEO, DT Technology Group. “Our initial partner choices, however, limited what we could deliver to customers as they were complicated to use, inflexible, and quite expensive. Virtuozzo Hybrid Infrastructure solved all of those problems out of the box.”
A Public Cloud for Modern Times
DT uses the OpenStack-based Virtuozzo Hybrid Infrastructure to host a robust 5G-enabled infrastructure supporting Public Cloud, Edge data centers, and OnPrem needs. The Cloud infrastructure scales easily and notably taps into local data centers to satisfy data sovereignty requirements. Further, its inherent capabilities driven by Virtuozzo’s hyperconverged system include support for various advanced solutions—from graphics-rich VDI services to compute-heavy, AI-dependent big data analytics.
A Digital Platform Partner for the DevOps Community
To help businesses capitalize on its robust infrastructure, DT also uses Virtuozzo’s software to deliver digital solutions. This offering includes consultative services as well as digital platform development—such as microservices architecture design—for cross-industry customers, and depends heavily on Virtuozzo Hybrid Infrastructure’s core features:
- Security and business continuity
- Production-ready Kubernetes environment and tools
- Flexible licensing models (PAYG pricing)
- Immediate scalability, up or down
- Storge-as-a-Service
- Hardware vendor agnostic
“Virtuozzo is purpose-built to help companies like DT shift their and their customers’ business models from capex to opex, helping reduce costs while gaining the benefits of hyperconverged, Cloud-driven digital transformation,” said Alex Fine, Virtuozzo CEO. “We’re seeing increased adoption of our technology by savvy service providers striving to deliver alternative Cloud services: services that compete with those of hyperscalers in diversity, performance and capabilities, but are simpler, more flexible, and far more cost-efficient to use. To that end, DT is optimizing Virtuozzo Hybrid Infrastructure to an incredible extent. We’re excited to see what they’ve accomplished to date and are proud to be a part of their continued journey.”
About DT Technology Group
Headquartered in Istanbul, DT Technology Group (www.dt.net.tr) is an international digital platform enabler servicing Turkey and other locations worldwide. Since its 2006 inception, DT has evolved from being an ICT systems integrator to a telco responsible for thousands of installations of carrier network infrastructure for 2G through to 5G networks. In 2018, the company packaged its experience to create an enterprise-grade, 5G-ready multiregional Public Cloud offering.
About Virtuozzo
Virtuozzo (www.virtuozzo.com) is a leading, global provider of hybrid virtualization, storage, and cloud enablement software solutions. The Company's software-defined, hyperconverged self-service platform and resource management capabilities enable hosting and service providers to provide end-customers with public and private cloud services. Virtuozzo is an industry pioneer who developed the first commercially available container technology 21 years ago. The Company provides software solutions and services to over 750 service providers, ISVs, and enterprises worldwide to enable hundreds of thousands of virtual environments, running mission-critical cloud workloads. A significant force in the open-source community, Virtuozzo sponsors and/or is a contributor to numerous open-source projects including KVM, Docker, OpenStack, OpenVZ, CRIU, and the Linux kernel.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211013005219/en/
Contact information
Heather Ailara/Deb Brown
211 Communications
+1.973.567.6040
heather@211comms.com
/
deb@211comms.com
Christine Brunelli
Virtuozzo
+1 215-847-7842
christine.brunelli@virtuozzo.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Yubico Appoints Poupak Modirassari Enbom as Chief Marketing Officer to Accelerate Global Momentum and Drive Market Leadership30.3.2026 16:00:00 EEST | Press release
Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and a leading provider of hardware authentication security keys, today announced the appointment of Poupak Enbom as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330278027/en/ Enbom joins Yubico at a pivotal moment as organizations worldwide accelerate the shift to phishing-resistant authentication and modern identity security in the age of AI. “We’re excited to welcome Poupak to Yubico,” said Jerrod Chong, acting chief executive officer, Yubico. “As the threat landscape evolves with AI-driven attacks and increasing automation, organizations are rethinking how they secure digital identities of both humans and AI agents at scale. She brings a unique combination of technical depth, global leadership, and customer-first mindset that will help us continue to expand our impact and support our customers and partners around
HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 15:00:00 EEST | Press release
HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate
Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 15:00:00 EEST | Press release
The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 500 million AGR uranium pellets and 222,000 AGR grids – which is equivalent to burning over 685 tonnes of coal, avoiding the emission of nearly 3 billion tonnes of CO2. Sp
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano ® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 14:00:00 EEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 14:00:00 EEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
